Savant Capital LLC Boosts Stock Position in IQVIA Holdings Inc. $IQV

Savant Capital LLC lifted its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 99.6% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 20,574 shares of the medical research company’s stock after buying an additional 10,266 shares during the period. Savant Capital LLC’s holdings in IQVIA were worth $3,242,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Malaga Cove Capital LLC lifted its holdings in IQVIA by 44.9% during the second quarter. Malaga Cove Capital LLC now owns 5,406 shares of the medical research company’s stock valued at $852,000 after purchasing an additional 1,676 shares in the last quarter. Modera Wealth Management LLC purchased a new stake in shares of IQVIA during the second quarter worth about $1,587,000. Graphene Investments SAS raised its position in shares of IQVIA by 22.7% during the 2nd quarter. Graphene Investments SAS now owns 18,400 shares of the medical research company’s stock worth $2,900,000 after purchasing an additional 3,400 shares during the last quarter. Resona Asset Management Co. Ltd. lifted its stake in IQVIA by 3.0% in the 2nd quarter. Resona Asset Management Co. Ltd. now owns 60,143 shares of the medical research company’s stock valued at $9,477,000 after buying an additional 1,734 shares in the last quarter. Finally, Ellevest Inc. boosted its holdings in IQVIA by 6.6% in the 2nd quarter. Ellevest Inc. now owns 1,934 shares of the medical research company’s stock worth $305,000 after buying an additional 120 shares during the last quarter. Institutional investors and hedge funds own 89.62% of the company’s stock.

IQVIA Stock Down 0.2%

NYSE IQV opened at $210.50 on Monday. The business’s fifty day simple moving average is $199.38 and its 200-day simple moving average is $176.50. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 2.03. The firm has a market cap of $35.85 billion, a PE ratio of 28.88, a P/E/G ratio of 2.35 and a beta of 1.34. IQVIA Holdings Inc. has a 52 week low of $134.65 and a 52 week high of $225.00.

IQVIA (NYSE:IQV) last released its quarterly earnings data on Tuesday, October 28th. The medical research company reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.98 by $0.02. IQVIA had a net margin of 8.07% and a return on equity of 30.70%. The firm had revenue of $4.10 billion during the quarter, compared to analysts’ expectations of $4.07 billion. During the same period last year, the business earned $2.84 earnings per share. IQVIA’s revenue was up 5.2% compared to the same quarter last year. IQVIA has set its FY 2025 guidance at 11.850-11.950 EPS. As a group, equities analysts anticipate that IQVIA Holdings Inc. will post 10.84 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on IQV shares. Truist Financial reissued a “buy” rating and set a $265.00 target price (up previously from $235.00) on shares of IQVIA in a report on Wednesday, October 29th. Evercore ISI boosted their price target on IQVIA from $220.00 to $240.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 8th. HSBC upgraded IQVIA from a “hold” rating to a “buy” rating and raised their price objective for the company from $195.00 to $235.00 in a report on Thursday, October 9th. JPMorgan Chase & Co. lifted their target price on shares of IQVIA from $177.00 to $255.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 29th. Finally, Redburn Partners set a $214.00 target price on shares of IQVIA in a research report on Wednesday, September 3rd. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $239.94.

Insider Activity at IQVIA

In other news, insider Eric Sherbet sold 4,000 shares of IQVIA stock in a transaction that occurred on Wednesday, October 29th. The shares were sold at an average price of $219.70, for a total transaction of $878,800.00. Following the sale, the insider owned 27,108 shares of the company’s stock, valued at approximately $5,955,627.60. The trade was a 12.86% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.60% of the company’s stock.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.